Value through Innovation27 July 2016

Clinical Study Results

  • MOBIC ® - Dysmenorrhea
    Clinical Study Number 107.191
    Study Indication Dysmenorrhea
    Product MOBIC ®
    Generic Name Meloxicam
    Lab Code
    Clinical Phase IIb
    Study Title

    Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of dysmenorrhea.

    Study Document Trial synopsis 107.191 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.